New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
Chadban
Steven
S
D017668:Age of Onset; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D018570:Risk Assessment; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects; D014181:Transplantation Immunology / Q000502:physiology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus